Chinese medicine stocks led the decline in the opening, and Huasen pharmaceutical once hit the limit
As of press time, Chinese medicine stocks led the decline in the opening, Huasen pharmaceutical once hit the limit, and Jiyao holdings, Yiling pharmaceutical, Zhongsheng pharmaceutical, Xintian pharmaceutical and Qianjin pharmaceutical followed the decline.
This text is a result of machine translation.
Related companies：
Briefing Mar 10, 2022 03:38 PM
· Automotive
The business scope of Evergrande automobile new company includes online car Hailing service
In-depth
Consumer Staples
The Overlooked 120 Million Consumers
Japan is a demanding but high-value market. Chinese sellers are growing fast, yet success requires more than low prices—clear manuals, strong quality, 24/7 service, and trust. Consumption is polarizing, and aging buyers remain active. Long-term branding and localization are key.
Oct 29, 2025 05:24 PM
Briefing Jan 13, 2022 03:19 PM
· Automotive
Haitong strategy: domestic infrastructure policy is expected to be strengthened this year
Dec 11, 2023 08:49 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Nov 08, 2022 08:32 AM
Survey: if the climate situation is not improved, six major cities in the world may sink before 2030
Briefing Oct 07, 2021 06:33 PM
· Automotive
Zhongyu group: investing in Evergrande notes and Evergrande auto shares will produce significant losses
Briefing Sep 29, 2021 10:11 AM
· Technology
"Paixun intelligence" announced the completion of tens of millions of yuan pre-A + round of financing
Briefing Sep 26, 2021 08:00 PM
· Automotive
Evergrande Motor announced on the Hong Kong stock exchange that the proposed issuance of RMB shares will not continue.
Briefing Sep 16, 2021 10:31 AM
· Automotive
Chevron CEO: natural gas and oil prices will be quite strong in the foreseeable future
See more
Read next
Insight
In-depth